Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).

Rimassa, LorenzaCicin, IrfanBlanc, Jean-FredericKlumpen, Heinz JosefZagonel, VittorinaTran, AlbertKim, Stefano Chong Hun2024-06-122024-06-1220180732-183X1527-7755https://doi.org/10.1200/JCO.2018.36.15_suppl.4090https://hdl.handle.net/20.500.14551/25935[Abstract Not Available]en10.1200/JCO.2018.36.15_suppl.4090info:eu-repo/semantics/closedAccess[No Keywords]Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).Conference Object3615Q1WOS:000442916001666